Advanced Practice Midwife in Onalaska, WI Accepting Medicare
6 Advanced Practice Midwife nurses found. Showing 1 - 6
 Theresa Hagen, CNM, RN, APNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 191 Theater Rd, Onalaska, WI 54650 Phone: 608-785-0940 |
Angela M Connely, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3111 Gunderson Rd, Onalaska, WI 54650 Phone: 608-782-7300 |
Jennifer H Meyers, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 191 Theater Rd, Onalaska, WI 54650 Phone: 608-392-5000 |
Hilary Anne Conn, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-775-8100 |
Ms. Jacqueline M Pierce, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-782-7300 |
Linda D Hirsh, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-782-7300 |
News Archive
New blood pressure targets are unachievable for most patients
New blood pressure targets are low enough to be unachievable for most patients, say experts from Aberdeen University in this week's BMJ.
FDA accepts Merck's SAFLUTAN NDA for standard review
Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck's investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S. Food and Drug Administration.
High SARS-CoV-2 antibody seroprevalence, low mortality at Austrian COVID-19 epicenter
Now, a new study reported on the preprint server medRxiv* in August 2020 describes a high seroprevalence in an Austrian ski resort, which is considered to be the source of the European outbreak.
Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.
› Verified 8 days ago
Registered Nurse
Nurse Practitioner
Physician Assistant
Advanced Practice Midwife
Licensed Practical Nurse